|
87%
agree
16 votes
|
Medicare part D |
|
66%
agree
3 votes
|
Good at increasing Same Store Sales in acquired stores |
|
50%
agree
2 votes
|
Recession moves customers towards CVS generics |
May 23, 2013
CVS Caremark (NYSE: CVS) is the largest U.S. pharmacy services provider.[1] It operates pharmacies, which sell prescription and Over the Counter (OTC) drugs, as well as retail merchandise such as cosmetics, convenience foods, and photo processing services. It also provides mail-order pharmaceutical services like prescription fulfillment. Through its businesses, CVS fills or manages more than 1 billion prescriptions per year.[2]
The company benefits from the increased demand for drugs from aging baby boomers, the general increase in prescription drug coverage over the last decade, and the expansion of government spending on health care through programs like Medicare Part D. However, the company does face challenges especially with its largest competitor Walgreen Company (WAG).
(Read more at Wikinvest
) - Company Overview
- Business Segments[3]
- Retail Pharmacy (59% of income)
- Pharmacy Services (41% of income)
- Medicare Part D Business
- Business Growth
- FY 2010 Earnings Summary[1]
- FY2011 Q1 Earnings Summary
- Key Trends and Forces
- Baby Boomers are Helping CVS' Profitability as They Age
- CVS Benefits from Economic Slowdown as Patients Migrate Toward Lower Cost Generics
- Health Reform Legislation Encourages Increased Drug Utilization
- When Major Drug Manufacturers Suffer, Retail Pharmacy Generics Prosper
- Competition
- References
